Harbor Investment Advisory’s Editas Medicine EDIT Stock Holding History

Harbor Investment Advisory’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-20	Closed	-$93	–	1201
2024 Q2	$93	Hold	20	–	–	﹤0.01%	1262
2024 Q1	$148	Hold	20	–	–	﹤0.01%	1303
2023 Q4	$203	Hold	20	–	–	﹤0.01%	1131
2023 Q3	$156	Hold	20	–	–	﹤0.01%	1160
2023 Q2	$165	Hold	20	–	–	﹤0.01%	1313
2023 Q1	$145	Hold	20	–	–	﹤0.01%	1310
2022 Q4	$177	Hold	20	–	–	﹤0.01%	1310
2022 Q3	$0	Hold	20	–	–	﹤0.01%	1338
2022 Q2	$0	Sell	20 -150	-88%	-$2.01K	﹤0.01%	1345
2022 Q1	$3K	Hold	170	–	–	﹤0.01%	1212
2021 Q4	$5K	Sell	170 -100	-37%	-$3.44K	﹤0.01%	1140
2021 Q3	$11K	Hold	270	–	–	﹤0.01%	1037
2021 Q2	$15K	Hold	270	–	–	﹤0.01%	946
2021 Q1	$11K	Hold	270	–	–	﹤0.01%	965
2020 Q4	$19K	Buy	270 +20	+8%	+$822	﹤0.01%	833
2020 Q3	$7K	Sell	250 -1,504	-86%	-$49K	﹤0.01%	893
2020 Q2	$52K	Hold	1,754	–	–	0.01%	433
2020 Q1	$35K	Sell	1,754 -1,800	-51%	-$45.4K	0.01%	465
2019 Q4	$105K	Buy	+3,554	New	+$88.8K	0.02%	322

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbor Investment Advisory's EDIT Position: Q3 2024 in Review

Harbor Investment Advisory sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 20 shares — an estimated $93 sold.

Harbor Investment Advisory first reported a position in EDIT in Q4 2019 and held it in 19 quarters. The position peaked at $105K in Q4 2019. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

Harbor Investment Advisory reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
Harbor Investment Advisory sold 20 Editas Medicine shares in Q3 2024, an estimated $93.
Harbor Investment Advisory first reported a position in Editas Medicine in Q4 2019 and held it in 19 quarters.
Harbor Investment Advisory's Editas Medicine position peaked at $105K in Q4 2019.
229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Harbor Investment Advisory's 13F filing for Q3 2024, filed 4 Oct 2024.